Issues in Medication Compliance Research
Abstract
Drug noncompliance poses a serious threat to the health of patients and to their financial well-being. Since Schwartz and her colleagues (1962) undertook their classic study of medication compliance among elderly patients, finding that 59% of them were making medication errors, researchers have been interested in studying this problem. A review of the literature indicates that, although there has been a considerable amount of research in this area, the prevalence of noncompliance persists. Estimates of non-compliance range from 15% to 93% (Brand & Smith, 1974; Martin & Coats, 1987; Robertson, 1985). The consequences of noncompliance are multifaceted. From a research standpoint, noncompliance clouds the efficacy of therapy and compromises the generalizability of clinical studies. For the patients, noncompliance may diminish the benefits of preventive or curative services. Additionally, it may foster both unnecessary diagnostic studies and treatments; this increases the cost and health risks to patients (Becker, 1985; Carey, 1984).Downloads
Published
1989-04-13
Issue
Section
Articles
License
Articles in this journal are made available under a Creative Commons Attribution License. Copyright has been assigned to the McGill Library and Archives. Authors retain all moral rights in their original work.